MAKE A DONATION
Crime and Incidents
Thinking About China
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
America Essay Contest
Business & Economy
China Human Rights
Organ Harvesting in China
Asia & Pacific
Business & Markets
ARTS & CULTURE
Fine Arts & Craftsmanship
Shen Yun Special Coverage
Film & TV
Tech Products & Reviews
American Thought Leaders
Family & Education
Film & TV
Fitness & Nutrition
Business & Markets
AstraZeneca Lifts Revenue Guidance on COVID-19 Treatment
AstraZeneca said it expected prescriptions of its COVID-19 therapy to drive sales growth of more than 20 percent this year, as company reported second-quarter profit that topped analyst estimates. The ...
July 30, 2022
AstraZeneca to Buy Oncology Firm TeneoTwo for Up to $1.27 Billion
AstraZeneca agreed to acquire biotechnology firm TeneoTwo Inc. in a deal worth up to $1.27 billion on Tuesday, ...
July 6, 2022
Studies Suggest Possible Link of Neuromyelitis Optica Diagnosis After COVID-19 Vaccination
Emergent peer-reviewed studies have highlighted the occurrence of neuromyelitis optica after COVID-19 vaccinations, suggesting that the autoimmune disease ...
June 18, 2022
‘Significant’ Cases of Neurological Disorder Associated With the AstraZeneca Vaccine
A UK study by University College London has confirmed “small but significant” cases of the serious Guillain-Barre syndrome ...
May 31, 2022
AstraZeneca Says Its COVID-19 Shot Still Has Role Despite Global Glut
AstraZeneca's COVID-19 vaccine still has a role to play in the fight against the pandemic, even as sales ...
April 30, 2022
AstraZeneca Predicts Revenue Hit as Demand for COVID-19 Vaccines Falls
Anglo-Swedish pharmaceutical giant AstraZeneca said that it expects the revenue from its COVID-19 vaccines to decline by up ...
April 29, 2022
MP Says Vaccine Manufacturer Not Answering ‘Basic Questions’ on Why Liability Clauses Were Requested
A Conservative MP says the president of the Canadian arm of AstraZeneca couldn't answer questions at a parliamentary ...
April 26, 2022
Canada Authorizes AstraZeneca’s Drug for COVID Prevention
Canada on Thursday authorized British drugmaker AstraZeneca Plc's antibody-based therapy for preventing COVID-19 infections, giving itself another weapon ...
April 14, 2022
AstraZeneca’s Imfinzi Fails Main Goal in Advanced Cervical Cancer Study
AstraZeneca said on Thursday its drug Imfinzi, along with chemoradiotherapy, failed to achieve the main goal of improving ...
March 25, 2022
AstraZeneca COVID Drug Performs Well Against Omicron Subvariants: Study
A COVID-19 drug made by AstraZeneca did nearly as well against subvariants of the Omicron virus variant as ...
March 21, 2022
AstraZeneca Pays $775 Million to Settle Drug Dispute With Japan’s Chugai
Anglo-Swedish drugmaker AstraZeneca Plc said on Thursday it would pay $775 million to settle a patent dispute with ...
March 18, 2022
Novavax Approved as Booster Alternative for Australians 18 and Over
The Novavax COVID-19 protein vaccine has been approved by the ATAGI as a booster alternative to mRNA vaccines for ...
March 2, 2022
AstraZeneca Sees Higher 2022 Sales, but Forecasts COVID-19 Shot Revenues to Decline
British–Swedish multinational pharmaceutical company AstraZeneca on Thursday forecast higher sales in 2022 after posting a better-than-expected fourth-quarter profit. But the ...
February 10, 2022
Moderna, AstraZeneca Partnering To Develop an ‘mRNA Therapeutic’ For Heart Disease
Drugmakers Moderna and AstraZeneca are partnering up to develop a "mRNA therapeutic” to treat life-threatening cardiovascular disease such ...
February 10, 2022
Isabel van Brugen
AstraZeneca Says Its COVID-19 Shot Given as Booster Works Against Omicron
AstraZeneca said its COVID-19 vaccine, called Vaxzevria, generated an antibody response against Omicron when given as a third ...
January 13, 2022
US Court Revives Lawsuit Against Pfizer, Others on Iraq Terrorism Funding Claims
A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc, Pfizer Inc and other companies over ...
January 5, 2022
‘Commercial Interests Colliding With Public Health’ in COVID-19 Vaccine Industry: Researcher
Billions of dollars in government funding ploughed into COVID-19 vaccine research during the pandemic has helped push the ...
January 2, 2022
Daniel Y. Teng
Some Vaccinated Australian Seniors Remain Hesitant on Vaccine Safety
Among older Australians who have said they were overwhelmingly likely to get a COVID-19 vaccine, some are still ...
December 24, 2021
AstraZeneca, Oxford Aim to Produce Omicron-Targeted Vaccine
AstraZeneca Plc said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron ...
December 22, 2021
The Week Ahead in Biotech (Dec. 19–25): Amgen and Aquestive Regulatory Decisions Key Events of Holiday-Shortened Week
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion ...
December 20, 2021
US FDA Approves AstraZeneca-Amgen Drug for Severe Asthma
The U.S. Food and Drug Administration (FDA) approved AstraZeneca and Amgen's drug, Tezspire, to treat severe asthma for ...
December 18, 2021
Pfizer Set to Oust AstraZeneca as Top Supplier of COVID-19 Shots to Poor Nations
BRUSSELS—Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global ...
December 16, 2021
AstraZeneca’s COVID-19 Prevention Drug Granted Emergency Authorization for Immune Compromised
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization on Dec. 8 for an AstraZeneca COVID-19 antibody ...
December 9, 2021
Prime Minister Sends Letters to Millions of Australians Encouraging COVID-19 Booster Shots
Letters will be sent to 11.3 million Australian homes before Christmas urging people to get COVID-19 booster shots, ...
November 25, 2021
Epoch Times Sydney Staff
AstraZeneca Plans to Begin Selling COVID-19 Vaccines at Profit
Pharmaceutical company AstraZeneca, which said it would not take a profit from its COVID-19 vaccines during the pandemic, ...
November 12, 2021
Australian Professor and COVID-19 Vaccine Developer Could Lose Job After Refusing Shots
Australian professor and vaccine developer Nikolai Petrovsky faces losing his job after refusing to get one of the Therapeutic ...
November 2, 2021
Rare A.30 COVID-19 Variant ‘Efficiently Evades’ Pfizer, AstraZeneca Vaccines: Study
An old COVID-19 variant called A.30—which is exceedingly rare—“efficiently evades” antibodies induced by the Pfizer-BioNTech and AstraZeneca vaccines, ...
October 29, 2021
Isabel van Brugen
Omicron Risk for Long COVID Is Lower Than Earlier Variants: Doctor
Dr. Yuhong Dong
The Chinese Regime Commits and Enables Human Trafficking: US State Dept Report
Danella Pérez Schmieloz
Takeaways From Tuesday Primaries: Four Trump-Backed Candidates Win, Omar Survives
Growing Number of Lawmakers Call on Biden Administration to Release Documents on FBI Raid of Trump
Trump Suggests FBI May Have ‘Planted’ Evidence During Mar-a-Lago Raid
Trump to Testify in New York Probe Into His Business Practices
‘We Have a Corrupt Medical System in This Country’: Sen. Ron Johnson
Food Price Inflation Soars to Record High In Germany
US Inflation Eases Slightly in July as Gas Prices Come Down
Health: COVID-19 Vaccine Causes Lung Blockages, According to New Science, Multiple Reports